Log in
TSE:HLS

HLS Therapeutics Stock Forecast, Price & News

C$14.25
-0.25 (-1.72 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
C$14.09
Now: C$14.25
C$14.59
50-Day Range
C$14.50
MA: C$16.21
C$17.93
52-Week Range
C$14.00
Now: C$14.25
C$25.92
Volume12,946 shs
Average Volume40,910 shs
Market CapitalizationC$452.34 million
P/E RatioN/A
Dividend Yield1.38%
BetaN/A
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and distributes pharmaceutical products in North American markets. It is focused on treatment products for the central nervous system and cardiovascular specialties. The company is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone647-495-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$53.86 million
Cash FlowC$1.06 per share
Book ValueC$5.31 per share

Profitability

Miscellaneous

Employees46
Market CapC$452.34 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
C$14.25
-0.25 (-1.72 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HLS News and Ratings via Email

Sign-up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











HLS Therapeutics (TSE:HLS) Frequently Asked Questions

How has HLS Therapeutics' stock price been impacted by COVID-19?

HLS Therapeutics' stock was trading at C$18.75 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HLS stock has decreased by 24.0% and is now trading at C$14.25.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of HLS Therapeutics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HLS Therapeutics in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for HLS Therapeutics
.

When is HLS Therapeutics' next earnings date?

HLS Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for HLS Therapeutics
.

How were HLS Therapeutics' earnings last quarter?

HLS Therapeutics Inc (TSE:HLS) released its quarterly earnings results on Thursday, August, 6th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.27. The company had revenue of $17.48 million for the quarter, compared to the consensus estimate of $19.19 million.
View HLS Therapeutics' earnings history
.

How often does HLS Therapeutics pay dividends? What is the dividend yield for HLS Therapeutics?

HLS Therapeutics declared a quarterly dividend on Wednesday, August 5th. Investors of record on Friday, October 30th will be given a dividend of 0.05 per share on Tuesday, December 15th. This represents a $0.20 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date is Thursday, October 29th.
View HLS Therapeutics' dividend history
.

Who are some of HLS Therapeutics' key competitors?

What other stocks do shareholders of HLS Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HLS Therapeutics investors own include Cargojet (CJT), Fairfax Financial Holdings Ltd Subordinate Voting Shares (FFH), Fortis (FTS), Aurora Cannabis (ACB), Aphria (APHA), Alimentation Couche-Tard (ATD.B), BlackBerry (BB), BCE (BCE), Bank of Montreal (BMO) and Bank of Nova Scotia (BNS).

Who are HLS Therapeutics' key executives?

HLS Therapeutics' management team includes the following people:
  • Mr. William M. Wells M.B.A., B.A., MBA, Co-Founder & Exec. Chairman (Age 58)
  • Mr. Gregory David Gubitz L.L.B., B.A., LL.B, Co-Founder, CEO & Director (Age 62)
  • Mr. Gilbert Godin, Pres & COO (Age 60)
  • Mr. Tim Hendrickson M.B.A., Chief Financial Officer (Age 48)
  • Mr. Ryan C. Lennox, Gen. Counsel & Corp. Sec. (Age 39)

What is HLS Therapeutics' stock symbol?

HLS Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HLS."

How do I buy shares of HLS Therapeutics?

Shares of HLS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is HLS Therapeutics' stock price today?

One share of HLS stock can currently be purchased for approximately C$14.25.

How big of a company is HLS Therapeutics?

HLS Therapeutics has a market capitalization of C$452.34 million and generates C$53.86 million in revenue each year. HLS Therapeutics employs 46 workers across the globe.

What is HLS Therapeutics' official website?

The official website for HLS Therapeutics is www.hlstherapeutics.com.

How can I contact HLS Therapeutics?

The company can be reached via phone at 647-495-9000.

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.